scispace - formally typeset
Y

Yu Wang

Researcher at University of Hong Kong

Publications -  385
Citations -  21817

Yu Wang is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 64, co-authored 205 publications receiving 19106 citations. Previous affiliations of Yu Wang include University of Auckland & Li Ka Shing Faculty of Medicine, University of Hong Kong.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

TL;DR: Adiponectin was effective in ameliorating hepatomegaly, steatosis, and alanine aminotransferase abnormality associated with nonalcoholic obese, ob/ob mice and could suppress the hepatic production of TNF-alpha and plasma concentrations of this proinflammatory cytokine.
Journal ArticleDOI

Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice

TL;DR: The effects of FGF21 on attenuation of obesity-induced impairment in insulin signaling in liver and skeletal muscle were abrogated in adiponectin knockout mice, whereas F GF21-mediated activation of ERK1/ERK2 in adipose tissues remained unaffected.
Journal ArticleDOI

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

TL;DR: A-fABP is a circulating biomarker closely associated with obesity and components of the metabolic syndrome, and measurement of serum concentrations of A-FABP might be useful for clinical diagnosis of obesity-related metabolic and cardiovascular disorders.
Journal ArticleDOI

Lipocalin-2 Is an Inflammatory Marker Closely Associated with Obesity, Insulin Resistance, and Hyperglycemia in Humans

TL;DR: Lipocalin-2 is an inflammatory marker closely related to obesity and its metabolic complications and might be useful for evaluating the outcomes of various clinical interventions for obesity-related metabolic and cardiovascular diseases.